ArticleHemaSphere2022

Preclinical Evidence for the Efficacy of CD79b Immunotherapy in B-cell Precursor Acute Lymphoblastic Leukemia.

Lennart Lenk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.